Squarer Ron (CIK 1454001) reported 8 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy NUVL (3,444 shares), Buy ADCT (45,000 shares), Sell ADCT (15,196 shares), Buy TVTX (4,000 shares), Buy NUVL (2,837 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Nuvalent, Inc. (NUVL) | Director | Buy | 3,444 | $0 |
| 2026-06-03 | ADC Therapeutics SA (ADCT) | Director | Buy | 45,000 | $0 |
| 2026-06-03 | ADC Therapeutics SA (ADCT) | Director | Sell | 15,196 | $46,804 |
| 2026-05-21 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,000 | $0 |
| 2025-12-11 | Nuvalent, Inc. (NUVL) | Director | Buy | 2,837 | $0 |
| 2025-06-17 | ADC Therapeutics SA (ADCT) | Director | Sell | 15,184 | $54,359 |
| 2025-06-05 | ADC Therapeutics SA (ADCT) | Director | Buy | 40,000 | $0 |
| 2025-05-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 6,500 | $0 |
Source: SEC Form 4 filings · as of 2026-06-18